Phase II trial of topotecan, cisplatin and bevacizumab for recurrent/persistent cervical cancer.
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin (Primary) ; Topotecan (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.